Cargando…
NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation
The poor sensitivity of clear cell renal cell carcinoma (ccRCC) to conventional chemotherapy and radiotherapy makes its treatment challenging. The Ndc80 kinetochore complex component (NUF2) is involved in the development and progression of several cancers. However, its role in ccRCC remains unclear....
Autores principales: | Lin, Jiatian, Chen, Xiangling, Yu, Hongjian, Min, Shasha, Chen, Yequn, Li, Zesong, Xie, Xina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254462/ https://www.ncbi.nlm.nih.gov/pubmed/35813477 http://dx.doi.org/10.7150/ijbs.70972 |
Ejemplares similares
-
LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription
por: Xie, Xina, et al.
Publicado: (2021) -
Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma
por: Shan, Li, et al.
Publicado: (2021) -
Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3
por: Lu, Bing, et al.
Publicado: (2022) -
NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma
por: Zheng, Baishu, et al.
Publicado: (2023) -
ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation
por: Lin, Qinghai, et al.
Publicado: (2020)